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Abstract. Brucellosis is a common bacterial zoonotic infection but data on the prevalence among humans and animals
is limited in Kenya. A cross-sectional survey was conducted in three counties practicing different livestock production
systems to simultaneously assess the seroprevalence of, and risk factors for brucellosis among humans and their livestock
(cattle, sheep, camels, and goats). A two-stage cluster sampling method with random selection of sublocations and house-
holds was conducted. Blood samples were collected from humans and animals and tested for Brucella immunoglobulin G
(IgG) antibodies. Human and animal individual seroprevalence was 16% and 8%, respectively. Household and herd sero-
prevalence ranged from 5% to 73% and 6% to 68%, respectively. There was a 6-fold odds of human seropositivity in
households with a seropositive animal compared with those without. Risk factors for human seropositivity included regular
ingestion of raw milk (adjusted odds ratio [aOR] = 3.5, 95% confidence interval [CI] = 2.8–4.4), exposure to goats (herding,
milking, and feeding) (aOR = 3.1, 95% CI = 2.5–3.8), and handling of animal hides (aOR = 1.8, 95% CI = 1.5–2.2).
Attaining at least high school education and above was a protective factor for human seropositivity (aOR = 0.3, 95%
CI = 0.3–0.4). This linked study provides evidence of a strong association between human and animal seropositivity
at the household level.
INTRODUCTION
Brucellosis, an infection caused by gram-negative bacteria
of the genus Brucella, is an economically important zoonotic
disease of humans, domesticated animals, marine mammals,
and wildlife. Six main species of Brucella are recognized,
four of which are identified as pathogenic to man. Brucella
melitensis, which predominantly affects goats and sheep,
is the most common cause of human brucellosis, whereas
B. аbortus, found mainly in cattle, buffalo, elk, yaks, and
camels, is the second most common cause of human infec-
tion. B. suis, which infects domestic pigs and rodents, and
B. canis in canines are increasing in importance as sources of
human brucellosis.1–3 The Food and Agriculture Organiza-
tion (FAO), the World Health Organization (WHO), and the
World Organisation for Animal Health (OIE) consider bru-
cellosis to be one of the most widespread zoonosis causing
substantial morbidity in both livestock and human populations
globally.4 Brucella is also a potential agent for bioterrorism
because of its propensity for airborne transmission and induc-
tion of a chronic debilitating disease that requires combined
and lengthy antibiotic therapies.5
Human brucellosis is mainly transmitted from animal res-
ervoirs through consumption of unpasteurized dairy products
and undercooked meat products, inhalation of contaminated
dust and contact with infected animal body fluids or tissues.6,7
Airborne transmission of Brucella to humans has also been
documented in clinical laboratories and abattoirs.4 Owing to
its low infectious dose, brucellosis poses an occupational risk
for farmers, veterinarians, abattoir workers, laboratory per-
sonnel, and others who work with animals and consume their
products.8,9 Clinically, human brucellosis presents as a febrile
disease with varied clinical manifestations that are dependent
on the stage of disease or the organs and systems involved.
This feature makes the disease an important differential
diagnosis for other important febrile diseases including
malaria, tuberculosis, and typhoid. Brucellosis is rarely fatal
but can be severely debilitating and disabling with a tendency
for chronicity and persistence. Acute brucellosis has been esti-
mated to have disability comparable to that of acute malaria,
whereas chronic, localized brucellosis has been estimated to
have disability comparable to osteoarticular disease.10 Brucel-
losis requires prolonged treatment with a combination of anti-
biotics, and can lead to permanent and disabling sequelae
with considerable financial and economic consequences.8,11
In animals, although specific Brucella species predominantly
infect cattle, sheep, goats, and camels, some Brucella species
are multi-host and it is common, for example, for the highly
virulent B. melitensis and B. suis to become established in
cattle. Transmission of Brucella in animals is mainly through
animal contact with infected aborted material, ingestion of
contaminated pastures or milk. Sexual transmission can occur
through natural mating or artificial insemination. The eco-
nomic burden arising from brucellosis in animals is associated
with productivity losses (longer calving intervals, reduced
growth, increased incidences of abortion, infertility, and calf
mortality), and restrictions on the trade and export of animals
and their products.12
The control of brucellosis has been achieved in many
developed countries. However, for other parts of the world
including Latin America, the Middle East, Spain, parts of
Africa, and western Asia brucellosis remains an endemic dis-
ease that causes more than 500,000 human infections each
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year.2,13 Most data on brucellosis in Africa have been
reported from north Africa, although these reports likely
underestimate the actual incidence. In Kenya, data on
human brucellosis are scarce even though it is considered a
priority disease.14 A study on patients presenting at a district
hospital with flu-like symptoms reported 13% prevalence of
brucellosis.15 Other studies have documented brucellosis
exposure in animals in Kenya at varying levels.16,17
Despite the public health importance of brucellosis, its
incidence and prevalence in animals and humans, as well as
its socioeconomic impact, remain poorly understood in
Kenya. In addition, despite its zoonotic transmission, few
studies have investigated the burden and risk factors for
animal and human brucellosis simultaneously among people
and livestock living together. Taking into consideration dif-
ferent animal production systems, our objective was to deter-
mine the seroprevalence of Brucella exposure through the
measurement of immunoglobulin G (IgG) antibody levels,
and the risk factors for brucellosis among human and animal
populations from the same household.
MATERIALS AND METHODS
Study design and sample size determination. We surveyed
three administrative counties, each representing a different
predominant livestock production system: Kiambu (small-
holder system), Kajiado (agropastoral system) and Marsabit
(pastoral system) (Table 1, Figure 1).18–20 Administratively,
each county is divided into subcounties, wards, and sub-
locations. Routine vaccination of animals against brucellosis
is rare in all three counties. A cross-sectional study design
was used. If a household consented to be part of the study,
all persons over 5 years of age and livestock (cattle, sheep,
goats and camels) living in the household were eligible for
inclusion into the study.
We calculated the number of persons to be sampled based
on an estimated seroprevalence of 50% for Kajiado and
Marsabit and 5% for Kiambu, with an error margin of 5%
and 2%, respectively, at the 95% confidence level.21 A
design effect of two was applied to account for clustering
and the sample size increased by 10% to account for non-
response, resulting in 730 persons for Kajiado and Marsabit
and 866 for Kiambu.
For animals, we used a seroprevalence of 15% for Kajiado
and Marsabit and 2% in Kiambu16 with an absolute precision
of 5% and 2%, respectively, at the 95% confidence level. To
account for clustering, a design effect of seven was applied
and the sample size increased by 10% to account for non-
response. The sample size was estimated to be 1,605 animals
per species in Kajiado and Marsabit and 1,548 per animal
species in Kiambu.
Sampling and data collection. We applied a two-stage ran-
dom sampling method to identify study households in each
county. In the first stage, sublocations were stratified by pre-
dominant production system and a 10% random sample was
subsequently selected in each stratum. This resulted in 21,
13, and 10 sublocations sampled in Kiambu, Kajiado, and
Marsabit counties, respectively. In the second stage, we first
calculated the number of households to be sampled within
each sublocation based on the total human population in the
sublocation, then randomly generated geographical coordinates
using ArcGIS to correspond to the number of households to
be sampled. Coordinates were loaded into a global positioning
system device to guide study teams in identifying households.
Each study team comprised a nurse, two veterinarians/paravets,
a laboratory technologist, one/two animal handlers, and a vil-
lage guide. Within the prescribed geocode, households were
randomly identified using the “spin the bottle” method.22
A household was defined as a group of people who use a
common cooking area. For each household, up to three per-
sons aged 5 years and above were randomly selected and
sampled. Sampling of the livestock was conducted per spe-
cies (cattle, goat, sheep, and camels) in proportion to size of
the herd. All animals in households with ≤ 15 animals were
sampled while for farms with larger herd sizes, a maximum
of 15 animals per species were sampled. Random animal
selection was attempted in this case.
In Kiambu and Kajiado counties, blood samples were col-
lected from eligible persons and from livestock between
November and December 2012. Sampling in Marsabit took
place in September 2013. Serum was separated from clotted
blood by centrifugation at 3,000 × g for 15 minutes at desig-
nated health facilities. Two milliliters of serum were stored at
−20°C for testing at the Center for Global Health Research,
Kenya Medical Research Institute (KEMRI)/Centers for Dis-
ease Control and Prevention (CDC) laboratory in Kisumu
(human samples), and the Central Veterinary Laboratory in
Nairobi (animal samples).
Structured questionnaires pre-loaded into smartphones were
administered by the team nurse to collect both household-
level and individual-level risk factors for brucellosis. The
team interviewed heads of households on types of livestock
kept, handling of livestock and their products, consumption
of animal products, history of brucellosis in the household,
level of education, socioeconomic status, demographic char-
acteristics, and herd management.
Serological testing. Human samples were tested using
the IBL-America IgG enzyme-linked immunosorbent assay
TABLE 1
Characteristics of the three study counties, Kenya, 2012–3013
Kajiado Kiambu Marsabit
Human population18 687,312 1,623,282 291,166
Human population density per km2,18 31 638 4















Average annual rainfall18 700 mm 1,000 mm 100 mm
Climate Semiarid Tropical wet Semiarid
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(ELISA) kits (Minneapolis, MN), whereas animal samples
were tested using Svanova Biotech AB (Uppsala, Sweden)
ELISA kits, that is SVANOVIR® Brucella-Ab I-ELISA kit
for cattle sera and SVANOVIR Brucella-Ab C-ELISA kit
for camel, goat, and sheep sera. All assays were performed
as recommended by the manufacturer. Briefly, human sera
were diluted at 1:10 with sample diluent, added to microtitre
plates pre-coated with Brucella antigen (Brucella abortus,
strain W99; lysate of a NaCl extract) and incubated at room
temperature for 1 hour. Conjugate was added and incubated for
30 minutes before adding substrate. The conjugate–substrate
reaction was terminated after 20 minutes by adding a stop
solution. Sample optical densities (ODs) were read at 450 nm.
Both conjugate and substrate addition steps were preceded by
a wash step, and all sera and controls were run in duplicates.
Samples were interpreted as positive, equivocal, or negative
based on readings of < 8, 8–12, and > 12, respectively, derived
from a plot of the OD of standards (y axis, linear) and their
concentrations (x axis, logarithmic). Equivocal samples were
not included in subsequent analysis.
Cattle sera were first incubated in Brucella antigen-coated
microtitre wells for 1 hour at 37°C followed by a wash step
and similar incubation conditions with a conjugate. Substrate
was then added following a wash step and the plates incu-
bated at room temperature for 10 minutes before the reaction
was terminated. Sample ODs were read at 450 nm and inter-
preted as positive or negative based on percent positivity (PP)
cutoff values of < 40 or ≥ 40, respectively. All other animal
sera were tested using competitive ELISA procedure. For
this procedure, sera together with a mouse monoclonal anti-
body were exposed to Brucella smooth lipopolysaccharide
(SLPS)-coated microtiter wells and incubated for 30 minutes,
followed by a 30 minutes conjugate- and 20 minutes substrate
incubation steps (all at room temperature) interspersed with
wash steps. The reaction was stopped and ODs read at
450 nm. Percent inhibition (PI) values were then calculated
and samples determined as negative for PI values < 30% or
positive if ≥ 30%.
Data analysis. All analyses were done using STATA 12
(Stata Corporation, College Station, TX). Risk factor analysis
was performed at the human, herd, and household levels,
whereas univariate analysis was performed on human demo-
graphic factors (age, gender, education, and primary occupa-
tion). The animal-related human factors analyzed included
livestock ownership, contact with or consumption of animals
or their products, and development of disease symptoms
within the last year. Factors characterizing animals or herds,
such as breed, age, herd size, grazing system, and breeding
system were also analyzed.
Brucella IgG serological status was used to indicate recent
or past exposure to brucellosis. Seroprevalence was deter-
mined at individual, household, and herd level, and a seropos-
itive household or herd was defined as any household with at
least one seropositive human or animal, respectively. Individ-
ual seroprevalence was defined as the proportion positive for
Brucella IgG among the sampled humans or animals.
Multivariate logistic regression was used to identify factors
associated with brucellosis seropositivity and to estimate the
magnitude of the adjusted odds ratios (aORs) for each factor
while controlling for other confounding factors. To account for
clustering, the svyset command in Stata 12 was used to specify
clustering at sublocation and household levels. All analyses
were subsequently carried out while accounting for clustering
by applying the prefix svy in Stata 12. Univariate analysis
FIGURE 1. Map of Kenya showing the three counties where the study was carried out. Each study county represents a predominantly unique
production system; Kiambu (small-holder system), Kajiado (agropastoral system) and Marsabit (pastoral system).20
226 OSORO AND OTHERS
was conducted for explanatory variables (biologically plausi-
bly associated with brucellosis seropositivity) and those with
a P value ≤ 0.2 were taken into the multivariate logistic
regression model. In the multivariate model, backward step-
wise selection was used until a minimum model in which all
explanatory variables had P values < 0.05 were realized. Each
dropped variable was added to the model separately to deter-
mine if it improved the fit. To determine the relationship
between human brucellosis and animal brucellosis, data were
summarized at the household level and the odds of human
seropositivity were determined depending on herd seroposi-
tivity. Confidence intervals at 95% were determined and a
P value < 0.05 was considered significant.
Ethical considerations. Ethical clearance and approval was
obtained from the KEMRI Ethical Review Committee (ERC)
and Animal Care and Use Committee (ACUC), and CDC
Institutional review board. Other approvals were obtained
from the Ministry of Health and the Ministry of Agriculture
Livestock and Fisheries. Appropriate consenting processes
were followed within households before sampling was initi-
ated and data confidentiality was strictly maintained.
RESULTS
Household characteristics. A total of 1,088 households
were surveyed; 505 (46%), 306 (28%), and 277 (26%) from
Kiambu, Kajiado, and Marsabit counties, respectively. The
mean household size was four persons (mean range = 4.1–4.5)
in the three counties. Among household heads (HHD),
72% were males and the mean age was 52.0 years (range =
18–94 years). Five percent of the household heads in
Marsabit County had at least high school education com-
pared with 46% and 56% in Kajiado and Kiambu, respec-
tively. Seventy-seven percent of the households owned at least
one livestock species (sheep, goat, cattle, and camels). Among
the livestock owning households, 73% owned cattle, 56%
owned goats, 45% owned sheep, and 12% owned camels.
Individual characteristics. A total of 2,811 persons, 1,255
(45%) from Kiambu, 791 (28%) from Kajiado and 765 (27%)
from Marsabit, consented and were interviewed. Fifty-four
percent of the persons interviewed were female. The mean
age was 35.6 years (range = 5–96 years). Table 2 below sum-
marizes the sociodemographic variables of the study partici-
pants by county. A total of 11,028 livestock (37% goats, 28%
sheep, 27% cattle, and 8% camels) were sampled. Camels
were only sampled in Marsabit and comprised 16% of the
livestock sampled in that county. Seventy-six percent of all
sampled livestock were female whereas 27% of all sampled
animals were sexually immature.
Brucellosis seroprevalence. Household and herd seropre-
valence. The highest household and herd prevalence was in
Marsabit and the lowest in Kiambu (Table 3). Forty-two per-
cent of all seropositive households had more than one seroposi-
tive individual. InMarsabit, 18% of the seropositive households
had all three individuals sampled positive for Brucella IgG,
whereas 70% of the seropositive herds had more than one ani-
mal seropositive compared with 27% and 18% of seropositive
herds inKajiado andKiambu, respectively.
Individual seroprevalence. Human seroprevalence was
generally 2- to 4-folds higher than animal seroprevalence in
all the counties. Human and animal seroprevalences were
highest in Marsabit County (Table 3). Human seroprevalence
was three times higher in Marsabit compared with Kajiado
and was six times higher in Kajiado compared with Kiambu.
Similarly in livestock, seroprevalence was four times higher
in Marsabit compared with Kajiado, which was about three
times higher compared with Kiambu. Among the livestock
species, camels and goats had the highest seroprevalence
(Table 4). Seroprevalence among sexually immature animals
was 3% compared with 10% among adult animals.
Factors associated with herd and household seropositivity. On
univariate analysis, risk factors identified as significantly
(P < 0.05) associated with human household seropositivity
included: ownership of sheep, goats, or camels, pastoralist pro-
duction system, nomadism, natural breeding (as opposed to
artificial insemination), acquisition of new animals into farm,
sold livestock from farm in previous 1 year, and male house-
hold head. The findings from the multivariate analysis are
presented in Table 5. Factors associated with herd sero-
positivity by univariate analysis included rearing sheep,
goats, or camels, pastoralist production system, nomadic
movements, use of natural breeding, acquiring animals into
farm, selling livestock from farm in previous 1 year, use of
calving pens as opposed to open calving, and mingling with
wildlife. The findings from the multivariate analysis are
presented in Table 5.
Human individual level factors. On univariate analysis, sig-
nificant factors (P < 0.5) that were protective against human
seropositivity included attaining at least secondary education,
consumption of processed dairy products, and previous treat-
ment of febrile illness. Risk factors for human seropositivity
on univariate analysis included male sex, using milk from
TABLE 2
Sociodemographic characteristics of study respondents, 2012–2013
Characteristic
Kajiado (N = 791),
No. (%)
Kiambu (N = 1,255),
No. (%)
Marsabit (N = 765),
No. (%)
Sex
Female 422 (53.4) 719 (57.3) 380 (49.7)
Male 369 (46.6) 536 (42.7) 385 (50.3)
Mean age (SD) 34.9 (18.5) 36.7 (19.2) 34.3 (19.9)
Education level
No education 201 (25.4) 57 (4.5) 518 (67.7)
Primary 335 (42.4) 569 (45.3) 191 (25.0)
Secondary 168 (21.2) 474 (37.8) 35 (4.6)
Post-secondary 84 (10.6) 152 (12.1) 16 (2.1)




342 (43.2) 618 (49.2) 386 (50.5)
Salaried, off farm,
skilled
49 (6.2) 130 (10.4) 42 (5.5)
Housewife 128 (16.2) 110 (8.8) 56 (7.3)
Salaried, off farm,
unskilled
18 (2.3) 103 (8.2) 89 (11.6)
Student 157 (19.9) 274 (21.8) 175 (22.9)
Other 97 (12.3) 20 (1.6) 17 (2.2)
SD = standard deviation.
TABLE 3
Seroprevalence of brucellosis at household and herd level, 2012–2013
Household seroprevalence (95% CI) Herd seroprevalence (95% CI)
All counties 28.0 (24.1–32.4) 29.9 (25.8–34.2)
Kajiado 28.6 (21.0–37.7) 30.3 (23.3–38.5)
Kiambu 5.0 (3.3–7.5) 5.6 (3.6–9.2)
Marsabit 73.4 (65.6–80.0) 68.0 (59.8–75.3)
CI = confidence interval.
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own cattle, regularly ingesting raw milk, exposure to live-
stock (herding, feeding, and milking), assisting animals in
delivery, handling hides, working with manure, cleaning
barns, and history of febrile illness. On multivariate analysis,
having secondary education and above was associated with
decreased risk of human brucellosis seropositivity. Exposure
to goats (herding, feeding, and milking), handling hides, and
regular use of raw milk were risk factors associated with
human brucellosis seropositivity (Table 6).
Linking human and animal brucellosis seropositivity. Uni-
variate analysis determining whether animal brucellosis
status was associated with human brucellosis at household
level was conducted, and results are shown in Table 7. In all
three study sites, the risk of human brucellosis increased up
to six times with animal brucellosis seropositivity in a house-
hold. The odds were greatest for households where camels
were seropositive for brucellosis.
DISCUSSION
This study used a “One Health” approach to simulta-
neously investigate the prevalence of brucellosis in humans
and livestock living in the same households. Although animals
are the main reservoirs for human brucellosis, studies on bru-
cellosis have mainly been conducted separately in humans
and animals.4,17,23 The uniqueness of this study design was
the simultaneous study of brucellosis in people and animals
living in the same households, allowing for identification and
quantification of risk factors for brucellosis transmission at
the household level. The study also provides a more complete
epidemiological picture and deepens the understanding of
infection patterns at the animal–human interface.24 The
approach has the added value of enhancing closer coopera-
tion between human and animal health practitioners.
Our study found that the odds of human seropositivity
were six times higher in households with a seropositive animal
compared with those without. Similar findings were reported
in a study in Kyrgyzstan.25 This association was highest if the
seropositive livestock was a camel or a goat consistent with
the hypothesis that human risk of brucellosis is a function of
the herd prevalence and depends both on the livestock spe-
cies reared and human-livestock contact.17,26,27 Conversely, it
contrasts results from a study in Togo and Mongolia where
no association was found between human and animal sero-
positivity.24,28 It is notable, however, that sampling in Togo
was done at the village level as opposed to household level.
The study in Mongolia found no correlation between cattle
and human seropositivity and only found a significant corre-
lation with sheep, but not for goats. In that study, sampling
was done at village level and livestock and human samples
were not necessarily collected from the same households.24
We think that the difference in sampling level could account
for the differences observed with our study.
Household and herd seroprevalence ranged from 5% to
73% and 6% to 68%, respectively, in the three counties with
seroprevalence highest in Marsabit. These results are similar
to those from another study conducted in Kenya, which
reported a cattle seroprevalence ranging from 2% (agricultural
high potential area) to 15% (semiarid, pastoralist area).16 Sim-
ilar differences based on predominant production system
have also been reported in Ethiopia and Uganda.29–31 The
livestock seroprevalence (13.5%) observed among pastoralist
communities in our study was lower than the 23% and 35%
reported among pastoralist communities in Jordan and Egypt,
respectively.32,33 Similarly, a higher livestock seroprevalence
TABLE 4
Seroprevalence of brucellosis in humans and livestock species by county, 2012–2013
Seroprevalence All counties % (95% CI) Kajiado% (95% CI) Kiambu % (95% CI) Marsabit % (95% CI)
Human 16.4 (13.5–19.6) 15.3 (10.5–21.8) 2.4 (1.9–3.0) 46.5 (39.0–54.1)
Livestock 8.0 (6.8–9.4) 3.3 (2.8–4.1) 1.2 (1.0–1.5) 13.5 (11.2–16.2)
Cattle 4.1 (3.4–4.8) 3.3 (3.0–3.5) 0.8 (0.5–1.1) 11.2 (9.2–13.7)
Goat 10.7 (9.3–12.3) 3.6 (2.7–4.7) 1.3 (1.0–1.8) 16.1 (13.9–18.5)
Sheep 7.3 (6.1–8.8) 3.4 (2.8–4.1) 2.4 (1.9–3.1) 11.9 (10.2–13.5)
Camel 11.1 (7.1–17.0) – – 11.1 (9.4–15.0)
CI = confidence interval.
TABLE 5
Multivariate logistic regression analysis of the factors associated with human household and herd seropositivity
All counties Kajiado Marsabit Kiambu
aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value
Human household positivity
Pastoral production system 6.8 (5.3–9.0) < 0.001 2.9 (2.1–4.0) < 0.001 – – 42.7 (21.1–86.5) < 0.001
Nomadic movements 3.4 (2.6–4.3) < 0.001 2.3 (1.7–3.2) < 0.001 5.7 (4.2–7.7) < 0.001 – –
Male household head 3.4 (2.9–3.9) < 0.001 4.5 (3.4–5.9) 0.005 2.5 (2.0–3.0) < 0.001 3.0 (2.0–4.7) < 0.001
Sold livestock from farm in previous 1 year 1.7 (1.5–2.0) < 0.001 2.2 (0.9–5.1) 0.074 1.4 (1.0–2.1) 0.054 2.1 (1.4–3.3) 0.001
Keeping cattle 0.5 (0.4–0.7) < 0.001 0.6 (0.4–1.0) 0.048 0.9 (0.6–1.3) 0.487 1.1 (0.3–4.0) 0.891
HHD with at least secondary education 0.4 (0.3–0.5) < 0.001 0.4 (0.4–0.5) < 0.001 0.4 (0.1–0.6) 0.001 0.5 (0.4–0.7) 0.001
Herd Seropositivity
Pastoral production system 9.8 (5.7–17.0) < 0.001 2.9 (1.1–8.0) 0.039 – – – –
Keeping goats 2.1 (1.3–3.7) 0.011 1.8 (0.6–5.6) 0.274 1.3 (0.5–3.6) 0.607 3.1 (1.0–9.7) 0.048
Keeping sheep 2.6 (1.6–4.1) < 0.001 2.7 (0.9–7.7) 0.066 4.0 (1.7–9.3) 0.005 3.5 (1.2–10.5) 0.027
Use of calving pens 2.0 (1.3–3.2) 0.005 4.4 (1.6–11.6) 0.007 1.5 (0.7–3.4) 0.246 0.2 (0.0–1.8) 0.045
Exposure to aborted game 0.3 (0.2–0.6) < 0.001 0.5 (0.2–1.2) 0.007 0.5 (0.2–1.8) 0.268 – –
aOR = adjusted odds ratio; CI = confidence interval.
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(6.5%) was found in an agro-based community in Uganda34
compared with Kiambu (1.2%).
The high seroprevalence in humans and livestock could
reflect the endemicity of brucellosis in some parts of Kenya.
Differences in human seroprevalence between the counties
are likely due to the predominant production systems. Prac-
tices that promote brucellosis transmission such as drinking
raw milk, nomadic movements, and use of common grazing
and drinking areas for livestock are more likely in the pasto-
ralist communities than agro-based communities.17
In this study, the seroprevalence among livestock species
was fairly similar within a county, though slightly higher in
goats or sheep. This finding could suggest that animal hus-
bandry practices applied in different production systems influ-
ence transmission of brucellosis in livestock. In addition,
there is possible cross-transmission of multiple Brucella spe-
cies among different livestock species at the household and
community level. Studies from Togo and Chad have found
low human and small ruminant seroprevalence compared
with that in cattle.28,35 In the Togo study, cattle seropreva-
lence was 9%, and < 1% among humans, whereas Brucella
antibodies were not detected in sheep or goats. In our study,
the seroprevalence in humans, goats, or sheep was propor-
tionately higher compared with the studies in Togo and
Chad, consistent with observations that B. melitensis that
predominantly affects sheep and goats is important in brucel-
losis transmission to humans.2 Alternatively, the predomi-
nant Brucella species in the two countries could be different
from those in Kenya where our study shows seropositivity in
all species of livestock. In a study conducted in central
Kenya, both B. arbotus and B. melitensis were isolated from
bovine milk and aborted fetus samples.36
The human individual prevalence of 16% is higher than
reported in other community level studies in Egypt (2%),37
Chad (4%),35 and Kyrgyzstan (9%).25 Seroprevalence studies
in high-risk populations reported 8% among abattoir
workers in Nigeria,38 22% among slaughter house workers in
Pakistan,39 and 40% in high-risk groups in Libya.37 These
findings indicate high seroprevalence in humans in Kenya in
the general population. This varying prevalence between
counties is likely driven by the seroprevalence in livestock
species, which also varies between counties. In our study,
goat had the highest prevalence in Kajiado and Marsabit
Counties, whereas sheep had the highest prevalence in
Kiambu County. It is also likely related to different practices
among the pastoralist communities in Marsabit and Kajiado,
which promote transmission of brucellosis.
At the herd level, independent risk factors included keep-
ing goats, keeping sheep, and use of calving pens. Goats and
sheep often feed near homesteads where abortions due to
brucellosis are likely to happen and could likely be exposed
to contaminated environment for longer periods compared
with the cattle and camels, increasing the likelihood of infec-
tion. Alternatively, goat and sheep could be more susceptible
to Brucella. Farmers who use calving pens may not dispose
the products of conception following calving, resulting in
concentration and contamination of the environment and
transmission of brucellosis within the herds. However, in
Kiambu County, use of calving pens was found to be protec-
tive. This could be due to different practices in this high-
potential agricultural production system compared with the
pastoral production system including proper disposal of pla-
centae and separating animals in peuperium from the rest of
the herd for a longer time.
At the individual human level, risk factors included
increasing age by decade, being male, regularly ingesting raw
milk, exposure to goats (herding, milking, and feeding), and
handling animal hides. These findings are consistent with
findings from other studies, which indicate that the risk of
human brucellosis is related to transmission through direct
contact with animals or their products or indirectly through
consumption of their products.24,40,41 The age-related increase
in seroprevalence is consistent with an endemic pattern of
infection in humans. In an endemic situation (where infection
is continuously present), persons are increasingly likely to
have become exposed with time and hence show increasing
positivity with age. Male household heads are likely to prop-
agate some cultural practices, which promote Brucella trans-
mission, for example, not boiling milk before drinking. On
the other hand, female household heads are likely to adhere
to safer practices because of more frequent exposure to health
workers while attending antenatal care or child welfare clinics.
Persons who handle hides often have direct contact with raw
TABLE 6
Significant risk factors associated with human brucellosis exposure analyzed by multivariate logistic regression
Combined Kajiado Kiambu Marsabit
aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value
Age by decade 1.2 (1.1–1.2) < 0.001 1.3 (1.2–1.4) < 0.001 1.6 (1.5–1.6) < 0.001 1.1 (1.0–1.2) 0.010
Male sex 1.6 (1.3–2.0) < 0.001 1.0 (0.7–1.4) 0.832 1.3 (0.6–2.7) 0.479 3.0 (2.2–4.0) < 0.001
Use of milk from own animals 2.6 (2.0–3.4) < 0.001 2.0 (1.4–3.0) 0.001 1.3 (0.7–2.5) 0.410 3.2 (1.7–5.8) 0.002
Regular ingestion of raw milk 3.5 (2.8–4.4) < 0.001 2.7 (1.9–3.9) < 0.001 – – 0.9 (0.6–1.4) 0.633
Assist in animal delivery 1.5 (1.2–2.0) 0.002 1.1 (0.6–2.0) 0.860 1.1 (0.7–11.7) 0.708 1.6 (1.1–2.3) 0.021
Exposure to sheep 1.6 (1.3–1.8) < 0.001 3.2 (2.1–5.0) < 0.001 0.6 (0.3–1.2) 0.135 2.0 (1.4–2.8) 0.002
Exposure to goats 3.1 (2.5–3.8) < 0.001 1.5 (0.9–2.5) 0.127 0.9 (0.4–1.9) 0.792 2.1 (1.4–3.2) 0.004
Handling of animal hides 1.8 (1.5–2.2) < 0.001 1.5 (1.2–2.0) 0.004 83.2 (24.9–278.7) < 0.001 1.4 (1.1–1.8) 0.005
Secondary education and above 0.3 (0.3–0.4) < 0.001 0.7 (0.5–0.9) 0.023 0.1 (0.0–0.5) 0.004 1.8 (0.4–7.7) 0.384
aOR = adjusted odds ratio; CI = confidence interval.
TABLE 7
Association between human and animal brucellosis seropositivity at
household level
OR 95% CI P value
Livestock 6.2 5.5–7.1 < 0.001
Goats 10.7 9.0–12.8 < 0.001
Sheep 4.2 3.4–5.1 < 0.001
Cattle 2.7 2.1–3.4 < 0.001
Camel 11.0 8.3–14.7 < 0.001
CI = confidence interval; OR = odds ratio.
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meat and carcasses of infected animals, and through which
infection probably occurs through cuts and wounds to bare
hands, or through splashing of infected blood or other fluid
to the conjunctiva.
This study has several limitations. First, the exclusion of
children < 5 years of age limits the generalizability of our data
to the entire population. Second, our testing methods report
apparent rather than true prevalence. However, given the
validity of the assays used, this difference is likely minimal.
The ELISA tests used detected only antibodies against IgG
but not IgM. It is possible that some participants could have
had acute infection and be IgM positive but IgG negative,
with the potential effect that the prevalence stated could be
an underestimate. However, a study on diagnostic methods
for brucellosis where IgG and IgM antibodies were measured
simultaneously found little difference in the assays.42,43 Third,
our use of pan-Brucella test kits limited our ability to distin-
guish antibodies against different Brucella species. Fourth,
given the cross-sectional nature of this survey, we could not
assess temporal variations in seroprevalence if these existed.
CONCLUSION
Our study gives evidence of a strong association between
human and animal seropositivity at household level. In par-
ticular, goat and camel seropositivity was strongly associated
with human seropositivity. There was higher prevalence of
brucellosis in human and livestock in the predominantly pas-
toralist communities. To estimate the burden of brucellosis
and identify appropriate interventions, it will be necessary to
conduct further research to estimate the incidence of brucello-
sis with molecular typing of Brucella strains circulating among
humans and livestock. Confirmation of transmission chains by
molecular analysis of strains isolated from humans and differ-
ent livestock species is warranted to determine the dominant
brucella species.44 A socioeconomic study would give a societal
perspective burden of the disease and help determine control
measures to be undertaken in different settings.
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